TCRTAlaunos Therapeutics, Inc.同业对比
Alaunos Therapeutics, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TCRT本股 | $5M#8 | — | 7.5x#12 | 973.0x#6 | -50.0%#6 | 10.8%#9 | -84500.0%#6 | -640.5%#12 | — | — | -30.9%#1 | — |
| APRE | $6M#1 | — | 0.2x#1 | — | — | 2.8%#10 | — | -32.8%#2 | — | — | -65.4%#2 | — |
| ALZN | $6M#2 | — | 1.0x#9 | — | — | -94.3%#14 | — | -151.2%#7 | — | — | — | — |
| PRPH | $6M#3 | — | — | 1.3x#2 | -35.8%#5 | 72.4%#2 | -415.4%#3 | — | -804.6%#4 | — | — | — |
| ACXP | $5M#4 | — | 0.7x#6 | — | — | 43.5%#5 | — | -97.7%#4 | — | — | — | — |
| PULM | $5M#5 | — | 2.1x#11 | 0.7x#1 | 7.0%#4 | 46.0%#4 | -66.2%#1 | -201.9%#8 | -235.7%#2 | — | — | — |
| PCSA | $5M#6 | 2.8x#3 | — | — | — | -14.5%#11 | — | — | — | — | -80.8%#3 | 0.8%#1 |
| IMNN | $5M#7 | — | — | — | — | — | — | — | — | — | — | — |
| XBIO | $5M#9 | — | 0.8x#7 | 1.6x#4 | 19.0%#3 | 32.3%#7 | -95.2%#2 | -44.1%#3 | -1516.8%#6 | 4#1 | — | — |
| RVPH | $5M#10 | — | 0.3x#2 | — | — | 33.6%#6 | — | -130.6%#6 | — | — | — | — |
| TRAW | $4M#11 | — | 0.4x#5 | 1.6x#3 | 1134.5%#1 | 105.5%#1 | -640.7%#4 | 79.2%#1 | — | — | -88.5%#4 | — |
| CVKD | $4M#12 | — | 1.0x#8 | — | — | -24.3%#12 | — | -323.5%#10 | -585.1%#3 | — | — | — |
| ERNA | $3M#13 | 0.0x#2 | 1.1x#10 | 5.9x#5 | 755.9%#2 | 68.4%#3 | -1601.2%#5 | -440.1%#11 | -1016.2%#5 | — | — | — |
| GRI | $3M#14 | — | 0.3x#3 | — | -100.0%#7 | -45.7%#13 | — | -116.3%#5 | — | — | -96.7%#5 | — |
| KALA | $3M#15 | 0.0x#1 | 0.4x#4 | — | — | 29.9%#8 | — | -298.3%#9 | -69.9%#1 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议